The Drug Enforcement Administration (DEA) is publishing this final rule to revise existing regulations for narcotic treatment programs (NTPs) to allow the operation of a mobile component associated with a DEA-registered NTP to be considered a coincident activity permitted under the NTP's registration. Based on these revisions, NTP registrants that operate or wish to operate mobile components (in the State in which the registrant is registered) to dispense narcotic drugs in schedules II-V at remote location(s) for the purpose of maintenance or detoxification treatment do not need a separate registration for such mobile component. This final rule waives the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of this rule. These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.
US Federal Register - DEA Telehealth Rules · June 28, 2021
DEA Registration Requirements for Narcotic Treatment Programs With Mobile Components
Original title: Registration Requirements for Narcotic Treatment Programs With Mobile Components
DEA permits mobile components of registered narcotic treatment programs to operate as coincident activities without separate registration, enabling remote dispensing of narcotic drugs for maintenance or detoxification treatment.
Published by US Federal Register - DEA Telehealth Rules. HealthSignal links to the original document; the summary above is extracted from the source text.